Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 2003

View Archived Issues

Gemin X claims novel compounds for cancer, viral infections and autoimmune diseases

Novel antitumor ecteinascidins reported by Spanish research team

CV Therapeutics describes novel fatty acid oxidation inhibitors

New prostanoid EP4 receptor agonists and their use in osteoporosis

Bayer claims new series of thiazole-based anti-HSV agents

Novel antibacterial dimeric vancomycin derivatives claimed by Theravance

New MMP inhibitors for arthritis and other disorders discovered at Leo

Novel neuraminidase inhibitors in early development at BioCryst

Two series of PDE4 inhibitors identified by Merck researchers

Active Biotech reports on recent progress

Potential use of DX-88 in the treatment of hereditary angioedema

Good safety and efficacy for INS-37217 in the treatment of perennial allergic rhinitis

Improved management of malignant liver tumors with ferucarbotran-enhanced MRI

Sonazoid-enhanced ultrasound reported to improve the detection of liver metastases

Mepolizumab reported to inhibit eosinophil function in asthma and allergy

Antiallergic effects of CAT-213 in grass pollen-sensitive subjects

Telik offers progress report

NicOx reviews phase II data for AZD-3582

Velcade NDA granted priority review

Endovasc plans to file Liprostin IND for diabetic neuropathy

Viragen's natural interferon alfa approved in South Africa

Phase II results announced for ISA-247 in psoriasis

Enrollment completed in phase III trial of Aptosyn/Taxotere in NSCLC

Gilead's Hepsera approved for marketing in E.U. countries

Nippon Kayaku to seek marketing clearance for gusperimus in Europe

SMP-114 now in phase II development in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...